首页> 外文期刊>Prehospital emergency care >Intraosseous devices: a randomized controlled trial comparing three intraosseous devices.
【24h】

Intraosseous devices: a randomized controlled trial comparing three intraosseous devices.

机译:骨内装置:比较三个骨内装置的随机对照试验。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Access to the circulation is mandatory for adequate treatment in medical emergency situations. Intraosseous (IO) infusion is a safe, fast, and effective alternative for gaining access to the circulation, if intravenous access fails. In the last decade, the IO method gained renewed interest. New devices have been developed, such as the Bone Injection Gun (BIG) 15G/18G and the First Access for Shock and Trauma 1 (FAST1). OBJECTIVE: To determine which IO needle is preferable for gaining IO access in patients requiring acute administration of fluids or medication in a prehospital setting. METHODS: In this single-blind prospective randomized trial, the IO needles were added to the equipment of the helicopter emergency medical services (HEMS) system. The HEMS nurses received training in proper use of all needles. Children (1-13 years) were randomized to the Jamshidi 15G or the BIG 18G, and adults (>or= 14 years) were randomized to the Jamshidi 15G, the BIG 15G, or the FAST1. All patients requiring acute administration of fluids or medication, without successful insertion of an intravenous (IV) catheter, were included. The IO needles were compared in terms of insertion time, success rate, bone marrow aspiration, adverse events during placement, and user satisfaction. RESULTS: Sixty-five adult and 22 pediatric patients were included. The treatment groups were similar with respect to age, gender, mortality, and trauma mechanism (p >or= 0.05). The median insertion times ranged from 38 seconds for the Jamshidi 15G to 49 seconds for the BIG 15G and 62 seconds for the FAST1 (p = 0.004). The devices did not differ with respect to success rates (adults overall 80% and children overall 86%), complication rates, and user satisfaction. CONCLUSIONS: The Jamshidi 15G needle could be placed significantly faster than the FAST1. The devices had similar success rates, complication rates, and user-friendliness. Intraosseous devices provide a safe, simple, and fast method for gaining access to the circulation in emergency situations.
机译:简介:为了在医疗紧急情况下获得充分治疗,必须进入血液循环。如果静脉内注射失败,骨内(IO)输注是一种安全,快速,有效的替代方法,可以进入循环系统。在过去的十年中,IO方法重新引起了人们的兴趣。已经开发出新的设备,例如15G / 18G骨注射枪和“冲击与创伤1的首次使用”(FAST1)。目的:确定在院前环境中需要急性输注液体或药物的患者,哪种IO针更适合获得IO通路。方法:在该单盲前瞻性随机试验中,将IO针添加到了直升机紧急医疗服务(HEMS)系统的设备中。 HEMS护士接受了正确使用所有针头的培训。儿童(1-13岁)被随机分为Jamshidi 15G或BIG 18G,成人(大于或等于14岁)被随机分为Jamshidi 15G,BIG 15G或FAST1。包括所有需要急性输注液体或药物但未成功插入静脉(IV)导管的患者。在插入时间,成功率,骨髓抽吸,放置期间的不良事件和用户满意度方面对IO针进行了比较。结果:包括65名成人和22名儿科患者。在年龄,性别,死亡率和外伤机制方面,治疗组相似(p>或= 0.05)。中值插入时间从Jamshidi 15G的38秒到BIG 15G的49秒到FAST1的62秒不等(p = 0.004)。这些设备在成功率(成人总体为80%,儿童总体为86%),并发症发生率和用户满意度方面没有差异。结论:Jamshidi 15G针的放置速度明显快于FAST1。这些设备的成功率,并发症发生率和用户友好度都差不多。骨内装置为紧急情况下的血液循环提供了一种安全,简单,快速的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号